NO864443L - Fremgangsmaate for fremstilling av terapeutisk aktive n-substituerte 3-piperidin- eller 3-pyridin-karboksylsyrederivater. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive n-substituerte 3-piperidin- eller 3-pyridin-karboksylsyrederivater.

Info

Publication number
NO864443L
NO864443L NO864443A NO864443A NO864443L NO 864443 L NO864443 L NO 864443L NO 864443 A NO864443 A NO 864443A NO 864443 A NO864443 A NO 864443A NO 864443 L NO864443 L NO 864443L
Authority
NO
Norway
Prior art keywords
piperidine
substituted
procedure
preparation
carboxylic acid
Prior art date
Application number
NO864443A
Other languages
English (en)
Other versions
NO864443D0 (no
Inventor
Michael R Pavia
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO864443D0 publication Critical patent/NO864443D0/no
Publication of NO864443L publication Critical patent/NO864443L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/78Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO864443A 1985-11-08 1986-11-07 Fremgangsmaate for fremstilling av terapeutisk aktive n-substituerte 3-piperidin- eller 3-pyridin-karboksylsyrederivater. NO864443L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79634585A 1985-11-08 1985-11-08
US89730886A 1986-08-21 1986-08-21

Publications (2)

Publication Number Publication Date
NO864443D0 NO864443D0 (no) 1986-11-07
NO864443L true NO864443L (no) 1987-05-11

Family

ID=27121724

Family Applications (1)

Application Number Title Priority Date Filing Date
NO864443A NO864443L (no) 1985-11-08 1986-11-07 Fremgangsmaate for fremstilling av terapeutisk aktive n-substituerte 3-piperidin- eller 3-pyridin-karboksylsyrederivater.

Country Status (15)

Country Link
EP (1) EP0221572B1 (no)
KR (1) KR900005023B1 (no)
CN (1) CN86107695A (no)
AT (1) ATE67756T1 (no)
AU (1) AU590172B2 (no)
CA (1) CA1270818A (no)
DE (1) DE3681690D1 (no)
DK (1) DK165919C (no)
ES (1) ES2040201T3 (no)
FI (1) FI864246A (no)
GR (1) GR3002842T3 (no)
NO (1) NO864443L (no)
NZ (1) NZ218170A (no)
PH (1) PH24683A (no)
PT (1) PT83705B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK704488D0 (da) * 1988-12-19 1988-12-19 Novo Industri As Nye n-substituerede azaheterocykliske carboxylsyrer
US4910312A (en) * 1985-11-08 1990-03-20 Warner-Lambert Company Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof
DK270488D0 (da) * 1988-05-18 1988-05-18 Novo Industri As Hidtil ukendte o-substituerede ketoximer
DK588189D0 (da) * 1989-11-22 1989-11-22 Novo Nordisk As Nye heterocykliske carboxylsyrer
DK93791D0 (da) * 1991-05-17 1991-05-17 Novo Nordisk As Nye heterocykliske carboxylsyrer
DK74593D0 (da) * 1993-06-23 1993-06-23 Novo Nordisk As Novel heterocyclic chemistry
IL112223A0 (en) * 1994-01-04 1995-03-30 Novo Nordisk As Pharmaceutical compositions for the treatment of neurological inflammatory conditions
AU5271696A (en) * 1995-04-07 1996-10-23 Novo Nordisk A/S Novel heterocyclic compounds
US5962449A (en) 1995-04-07 1999-10-05 Novo Nordisk A/S Tricyclic compounds in treating hyperalgesic conditions and NIDDM
EP0825984A1 (en) * 1995-04-07 1998-03-04 Novo Nordisk A/S Novel method
CA2217202A1 (en) * 1995-04-07 1996-10-10 Novo Nordisk A/S Novel heterocyclic compounds
US5952352A (en) * 1995-04-07 1999-09-14 Novo Nordisk A/S Heterocyclic compounds
WO1996031503A1 (en) * 1995-04-07 1996-10-10 Novo Nordisk A/S Novel heterocyclic compounds
US6191165B1 (en) 1996-05-31 2001-02-20 Allelix Neuroscience Inc. Pharmaceutical for treatment of neurological and neuropsychiatric disorders
CZ20032503A3 (cs) 2001-02-16 2004-02-18 Allelix Neuroscience, Inc. Inhibitory GlyT - 1

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929813A (en) * 1973-12-26 1975-12-30 Interx Research Corp Novel pro-drug derivatives of pyridinium aldoxime type cholinesterase reactivators and process for preparing same
AU552050B2 (en) * 1981-05-26 1986-05-22 Smithkline Beckman Corporation N-substituted azeheterocyclic carboxylic acids and their esters

Also Published As

Publication number Publication date
GR3002842T3 (en) 1993-01-25
EP0221572A3 (en) 1987-07-29
PH24683A (en) 1990-09-07
AU6481286A (en) 1987-05-14
NZ218170A (en) 1990-07-26
ES2040201T3 (es) 1993-10-16
ATE67756T1 (de) 1991-10-15
FI864246A0 (fi) 1986-10-20
CN86107695A (zh) 1987-05-13
DK528086D0 (da) 1986-11-05
FI864246A (fi) 1987-05-09
AU590172B2 (en) 1989-10-26
DK165919B (da) 1993-02-08
EP0221572B1 (en) 1991-09-25
DE3681690D1 (de) 1991-10-31
DK528086A (da) 1987-05-09
CA1270818A (en) 1990-06-26
KR870004955A (ko) 1987-06-02
EP0221572A2 (en) 1987-05-13
DK165919C (da) 1993-06-28
NO864443D0 (no) 1986-11-07
PT83705B (pt) 1989-05-12
PT83705A (en) 1986-12-01
KR900005023B1 (ko) 1990-07-18

Similar Documents

Publication Publication Date Title
NO864443L (no) Fremgangsmaate for fremstilling av terapeutisk aktive n-substituerte 3-piperidin- eller 3-pyridin-karboksylsyrederivater.
ATE71629T1 (de) Methylenphosphonalkylphosphinate, pharmazeutische zubereitungen und verfahren zur behandlung abnormalen kalzium- und phosphat-stoffwechsels.
ATE117553T1 (de) Substituierte dihydroisochinolinone und verwandte verbindungen als verstärker der letalen effekte von bestrahlung und bestimmten chemotherapeutika; ausgewählte verbindungen, analoga und verfahren.
LU88317I2 (fr) Chlorhydrate d'esmolol (Brevibloc)
NO172580C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte n-(1-alkyl-3-hydroksy-4-piperidinyl)benzamider
ATE103808T1 (de) N-(3,4-dimethoxycinnamoyl)-anthranilsaeure enthaltende arzneimittelzusammensetzungen.
ATE416164T1 (de) Pharmazeutische zusammenstellungen zur prävention und behandlung von zns-erkrankungen
ATE85523T1 (de) Taurohyodeoxycholsaeure zur behandlung von gallenwegssteinen und gallenstoerungen.
ES2068194T3 (es) Alfa-aminoacidos substituidos que tienen actividad farmaceutica.
BR0008778A (pt) Análogos de prostaglandinas seletivos para fpc16 insaturados
FI91876B (fi) Menetelmä nootrooppisen vaikutuksen omaavien aminohappojohdannaisten valmistamiseksi
EP0346927A3 (en) Various n-substituted 3-piperidine carboxylic acids or n-substituted 3-pyridine-carboxylic acids and derivatives thereof
ATE69049T1 (de) Chinazolin-derivat, verfahren zu dessen herstellung und mittel zur behandlung von cerebraler disfunktion als aktiver inhaltsstoff.
NO173991C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,5-ditiazocin-derivater
DK166384C (da) Analogifremgangsmaade til fremstilling af (-)-15-deoxyspergualing og farmaceutisk acceptable syreadditionsssalte heraf samt mellemprodukt
NO891071D0 (no) Fremgangsmaate for fremstilling av 4,5,6,7-tetrahydro-isotiazolo(4,5-c)-pyridinderivater og isomere.
ATE58521T1 (de) Lysinsalz der 4-biphenylessigsaeure und es enthaltende augenheilmittel.
DE3162277D1 (en) N-(4-phenyl-2-thiazolyl)-oxamidic-acid-2-ethoxyethylester, process for its preparation and pharmaceutical compositions containing this compound
NO873571L (no) Fremgangsmaate for fremstilling av et terapeutisk virksomtpreparat.
DK0573260T3 (da) Nye alkaloidderivater, deres anvendelse og farmaceutiske formuleringer, der indeholder dem